The Adolescent Partial Hospitalization Program provides a full day intensive group therapy treatment program whose goal is to prevent psychiatric inpatient hospitalization or to offer additional support as a step down from an inpatient stay. The adolescent program is for ages 13- 17. • Based on ...
The SARS-CoV-2 main protease (3CLpro) is one of the promising therapeutic targets for the treatment of COVID-19. Nirmatrelvir is the first 3CLpro inhibitor authorized for treatment of COVID-19 patients at high risk of hospitalization. We recently reported on the in vitro selection of SARS...